A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma
Clinical trial NCT05064852 · UNKNOWN
Trial details
- NCT number
- NCT05064852
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-20
- Primary completion
- 2022-12-20
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.